RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        Changi Airport Group (CAG): A Cut Above the Rest

        Brandon KOH Wai Loong,Joel CHAN Yung Min,WONG Soon Mark,YEE Jek Hui Darryl,Wendy LIM Wan Jun Academy of Asian Business (AAB) 2019 Academy of Asian Business Review Vol.5 No.2

        This study analyses the factors that contributed to the rise and success of the Changi Airport Group (CAG) in the aviation industry. The history of CAG can be segmented into three main periods: the rapid growth of the aviation industry from 1970-2000, the incorporation of Industry 4.0 technologies that maintained CAG’s growth from 2000-2009 and the change of cultural perspectives and strategic design from 2009 to the present that propelled CAG to the success story that it is today. The first period examines the strategic importance of foresight and planning future infrastructure to capture a market that is undergoing a phase of exponential demand. The second period elucidates on the significance of incorporating technologies to distinguish itself in a highly competitive industry and amidst external threats. The last period reveals how change is critical to counter weaknesses in strategic design and in cultural and political issues. Besides these strategic moves, several factors were also integral to the company’s success. They illustrate that firstly, unparalleled service excellence is critical in capturing market demand. Secondly, engaging in corporate social responsibility is crucial in establishing an excellent brand identity. Lastly, being forward looking in building infrastructure and innovatively incorporating technology in meeting industry needs will help maintain a company’s growth even with periods of stagnation. These practices can be adopted by companies experiencing rapid growth and subsequently, stagnation, as they reinvent themselves in today’s evolving global landscape. From the turning points and success factors of CAG, the key takeaways we discovered were that change, innovation and foresight help deal with future threats and existing weaknesses. Lastly, a brand identity can be a success if it serves the needs and incorporates values that resonate with people.

      • SCOPUSKCI등재

        Comparison of Cytotoxic Activities between in Vitro and Field Grown Plants of Typhonium flagelliforme (Lodd.) Blume

        ( Lai Keng Chan ),( Wan Yee Koh ),( Tengku S. Tengku Muhammad ) 한국식물학회 2005 Journal of Plant Biology Vol.48 No.1

        An in vitro cytotoxicity screening of the Typhonium flagelliforme extracts indicated high cytotoxicity effect on human lung carcinoma NCI-H23 cells and human mammary gland carcinoma T-47D cells, but the extracts were not active on human liver carcinoma HepG2 cells. NCI-H23 cells were more susceptible to T. flagelliforme extracts than T -47D cells. ED50 values of the hexane fractions of the mature plant and the in vitro plantlet of T. flagelliforme on NCI-H23 cells were less than 2 ㎍/mL. Extract from the mature plant was relatively more cytotoxic than the one from in vitro plantlet except for the hexane fraction. The chloroform and butanol fraction of the mature plant had higher cytotoxicity effect than the fraction from in vitro plantlet on NCI-H23 cells. All the 3 fractions (hexane, chloroform, and butanol) of the mature plant exhibited higher cytotoxicity effects on human mammary gland carcinoma T -47D cells than the 3 fractions of in vitro plantlet. However, the human liver carcinoma cells were resistant to T. flagelliforme extracts except for higher concentration of hexane fractions of both the mature and the in vitro plants and the chloroform fraction of the mature plant. Micropropagated plantlets of T. flagelliforme could hence be used as herbal materials for the treatment of human lung and breast cancers.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼